GLP-1 Education · 069
Recognize Confounding by Indication in GLP-1 Research
Confounding by indication occurs when the reason for receiving treatment also relates to the outcome.
Dr. Sherry-Ann Brown, MD, PhD, FACC, FAHA
The research question
Confounding by indication occurs when the reason for receiving treatment also relates to the outcome. Disease severity, prior treatment response, weight trajectory, and cardiovascular history may influence prescribing. Access and preference can add further differences. Researchers need to describe these influences when building a comparative observational study.
How to interpret the evidence
An active comparator can improve the clinical relevance of a comparison when both treatments address a similar decision. A new-user design helps align entry with treatment initiation. Investigators also need clearly measured baseline variables and appropriate analytic methods. Residual uncertainty remains part of the result, particularly when important clinical characteristics are poorly captured in records.
The retrospective GLP-1 hair loss cohort provides a relevant study design to examine critically. The design suggestions in this article are original methodological teaching.
Covariate measurement should precede the exposure when the analysis intends to adjust for baseline confounding. A variable affected by treatment may play a different causal role. The research question guides that distinction. A clinical and statistical design discussion can clarify which factors belong in the baseline model and which require another analytic approach.
Practice the appraisal
Original design exercise: list the reasons a clinician might choose one metabolic therapy over another. Separate factors recorded reliably in a dataset from factors often captured in free text or omitted. Consider prior gastrointestinal intolerance, patient goals, insurance rules, and disease severity as hypothetical examples. Check whether the observational study measured these before treatment began. Ask how an active comparator changes the clinical decision being represented. Finish by writing the clearest limitation arising from treatment selection and one feasible improvement for a future study.
Apply the lesson
When planning a cohort, invite a clinician familiar with prescribing decisions to review the covariate list. Clinical insight can reveal treatment-selection factors that a database dictionary may obscure. Examine whether those factors are measured before treatment begins and whether their quality is adequate. The resulting manuscript should describe the clinical comparison and the remaining uncertainty in language that readers can follow.